Published in Arch Dermatol on July 01, 1974
Herpes gestationis. Immunopathology and characterization of the HG factor. J Clin Invest (1976) 1.34
The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of "HG factor". J Clin Invest (1976) 1.33
High frequency of histocompatibility antigens HLA-DR3 and DR4 in herpes gestations. J Clin Invest (1981) 0.93
Rapid identification of monocytes in a mixed mononuclear cell preparation. J Immunol Methods (1977) 4.12
Basement zone antibodies in bullous pemphigoid. JAMA (1967) 2.66
Focal dermal hypoplasia syndrome. A review of the literature and report of two cases. Arch Dermatol (1970) 2.33
Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med (1982) 2.26
The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest (1976) 2.19
The immunopathology of pemphigus and bullous pemphigoid. J Invest Dermatol (1968) 2.17
Focal dermal hypoplasia syndrome. An update. Arch Dermatol (1992) 1.88
Complement immunofluorescent staining in bullous pemphigoid. J Lab Clin Med (1969) 1.83
Guidelines of care for warts: human papillomavirus. Committee on Guidelines of Care. J Am Acad Dermatol (1995) 1.43
Direct immunofluorescent studies of pemphigus and bullous pemphigoid. Arch Dermatol (1971) 1.39
Immunofluorescence of cutaneous vasculitis associated with systemic disease. Arch Dermatol (1971) 1.38
Nodular fasciitis: response to intralesional corticosteroids. J Am Acad Dermatol (1999) 1.35
The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of "HG factor". J Clin Invest (1976) 1.33
Circulating immune complexes in active Behçet's disease. Clin Exp Immunol (1978) 1.32
Skin changes secondary to hydroxyurea therapy. Arch Dermatol (1975) 1.29
Cutis laxa. A manifestation of generalized elastolysis. Arch Dermatol (1965) 1.28
Vasculitis in granuloma annulare: histopathology and direct immunofluorescence. Arch Dermatol (1977) 1.28
Leukocytoclastic vasculitis. A cutaneous expression of immune complex disease. Arch Dermatol (1982) 1.26
The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody. J Lab Clin Med (1975) 1.24
The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids. J Clin Invest (1973) 1.20
Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b. Immunology (1978) 1.18
The complement system in bullous pemphigoid. II. Immunofluorescent evidence for both classical and alternate-pathway activation. Clin Immunol Immunopathol (1975) 1.17
Correlation of pemphigoid and pemphigus antibody titres with activity of disease. Br J Dermatol (1971) 1.15
T and B lymphocytes in contact and atopic dermatitis. Arch Dermatol (1976) 1.15
Negative complement immunofluorescence in pemphigus. J Invest Dermatol (1971) 1.15
Oral pemphigus vulgaris. A report of ten cases. Arch Dermatol (1977) 1.14
Classical and alternate pathway activation of complement in pemphigus vulgaris lesions. J Invest Dermatol (1974) 1.11
Guidelines of care for superficial mycotic infections of the skin: tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis. Guidelines/Outcomes Committee. American Academy of Dermatology. J Am Acad Dermatol (1996) 1.10
Cutaneous vascular immunofluorescence in rheumatoid arthritis. Correlation with circulating immune complexes and vasculitis. Am J Med (1980) 1.09
Childhood bullous dermatitis herpetiformis. Negative immunofluorescent tests. Arch Dermatol (1970) 1.07
Immunoglobulin and complement deposition in skin of rheumatoid arthritis and systemic lupus erythematosus patients. Ann Rheum Dis (1976) 1.07
Incidence of skin carcinoma after renal transplantation. Arch Dermatol (1977) 1.04
Comparison of three immunoassays for immune complexes in rheumatoid arthritis. Arthritis Rheum (1979) 1.04
T and B lymphocytes in atopic eczema. Arch Dermatol (1974) 1.03
Erythema multiforme: direct immunofluorescence studies and detection of circulating immune complexes. J Invest Dermatol (1980) 1.03
Mononuclear cell stimulation of fibroblast collagen synthesis. Clin Exp Dermatol (1978) 1.02
Lupus erythematosus profundus with periorbital swelling and proptosis. J Am Acad Dermatol (1991) 1.02
Case report. Haemophilus parainfluenzae epiglottitis with meningitis and bacteremia in an adult. Am J Med Sci (1974) 1.02
Pemphigus antibodies: their role in disease. J Invest Dermatol (1971) 1.00
Leukonychia totalis, multiple sebaceous cysts, and renal calculi. A syndrome. Arch Dermatol (1975) 0.99
Oral tetracycline treatment on bacterial flora in acne vulgaris. Arch Dermatol (1966) 0.99
Immunopathologic mechanisms in pemphigus and bullous pemphigoid. J Invest Dermatol (1985) 0.99
Complement activation in bullous skin diseases. J Invest Dermatol (1975) 0.98
Bullous pemphigoid antigen: isolation from normal human skin. J Immunol (1977) 0.98
Inflammation in acne vulgaris: leukocyte attraction and cytotoxicity by comedonal material. J Invest Dermatol (1980) 0.96
C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay. Clin Exp Immunol (1977) 0.96
Complement activation in pemphigus and bullous pemphigoid. J Invest Dermatol (1976) 0.96
Vasculitis in chronic urticaria: an immunopathologic study. J Invest Dermatol (1981) 0.95
Subcutaneous T-cell lymphoma with associated hemophagocytic syndrome and terminal leukemic transformation. J Am Acad Dermatol (1996) 0.95
Antinuclear antibodies: their significance in scleroderma. Mayo Clin Proc (1971) 0.95
Diffuse normolipaemic plane xanthomatosis. An abnormal complement component profile. Clin Exp Immunol (1974) 0.94
Sclerodermatous graft-versus-host disease limited to an area of measles exanthem. Lancet (1978) 0.94
Dialysis therapy for psoriasis. JAMA (1978) 0.94
Deposition of the membrane attack complex of complement in pemphigus vulgaris and pemphigus foliaceus skin. J Invest Dermatol (1989) 0.93
Subclass distribution of human IgG autoantibodies in pemphigus. J Clin Immunol (1988) 0.93
Guidelines of care for the use of topical glucocorticosteroids. American Academy of Dermatology. J Am Acad Dermatol (1996) 0.93
Complement fixation by pemphigus antibody. II. Complement enhanced detachment of epidermal cells. Clin Exp Immunol (1985) 0.93
Direct immunofluorescence in the diagnosis of scleroderma syndromes. Br J Dermatol (1977) 0.91
Guidelines of care for actinic keratoses. Committee on Guidelines of Care. J Am Acad Dermatol (1995) 0.91
Guidelines of care for basal cell carcinoma. The American Academy of Dermatology Committee on Guidelines of Care. J Am Acad Dermatol (1992) 0.91
Guidelines of care for dermatomyositis. American Academy of Dermatology. J Am Acad Dermatol (1996) 0.90
Recombinant desmoglein 3 has the necessary epitopes to adsorb and induce blister-causing antibodies. J Invest Dermatol (1996) 0.90
Study of elastolytic activity Propionibacterium acnes and Staphylococcus epidermis in acne vulgaris and in normal skin. Acta Derm Venereol (1976) 0.89
Guidelines of care for Mohs micrographic surgery. American Academy of Dermatology. J Am Acad Dermatol (1995) 0.89
Guidelines of care for superficial mycotic infections of the skin: Pityriasis (tinea) versicolor. Guidelines/Outcomes Committee. American Academy of Dermatology. J Am Acad Dermatol (1996) 0.89
Erythrokeratodermia variabilis treated with isotretinoin. A clinical, histologic, and ultrastructural study. Arch Dermatol (1986) 0.89
Erythropoietic protoporphyria. II. Histological and histochemical studies of cutaneous lesions. Arch Dermatol (1965) 0.89
Complement fixation by pemphigus antibody. III. Altered epidermal cell membrane integrity mediated by pemphigus antibody and complement. J Invest Dermatol (1986) 0.89
Separation of epidermis from dermis with sodium thiocyanate. J Invest Dermatol (1977) 0.88
"An unusual type of pemphigus combining features of lupus erythematosus" by Senear and Usher, June 1926. Commentary: Pemphigus erythematosus, a unique member of the pemphigus group. Arch Dermatol (1982) 0.88
Guidelines of care for photoaging/photodamage. American Academy of Dermatology. J Am Acad Dermatol (1996) 0.87
Serum and blister fluid anticomplementary activity in pemphigus and bullous pemphigoid. Sucrose density gradient studies. Proc Soc Exp Biol Med (1976) 0.87
Complement fixation by pemphigus antibody. I. In vitro fixation to organ and tissue culture skin. J Invest Dermatol (1984) 0.87
Skin changes in graft-vs-host disease. South Med J (1976) 0.87
Chronic urticaria-like lesions in systemic lupus erythematosus. A review of 12 cases. Arch Dermatol (1978) 0.87
Letter: Immunoglobulins and complement in skin in graft-versus-host disease. Ann Intern Med (1976) 0.86
Unusual cutaneous infections associated with immunosuppressive therapy. Arch Dermatol (1967) 0.86
Oesophageal involvement in bullous pemphigoid. A possible cause of gastrointestinal haemorrhage. Br J Dermatol (1978) 0.86
Tetracycline levels in skin surface film after oral administration of tetracycline to normal adults and to patients with acne vulgaris. J Invest Dermatol (1967) 0.86
Pemphigus immunoglobulin G subclass autoantibodies: studies of reactivity with cultured human keratinocytes. J Lab Clin Med (1990) 0.86
The complement system in pemphigus, bullous pemphigoid and herpes gestationis. Int J Dermatol (1979) 0.86
Pyoderma gangrenosum, rheumatoid arthritis, and diabetes mellitus. Arch Dermatol (1966) 0.85
Pemphigus-like antibodies in bullous pemphigoid. Arch Dermatol (1977) 0.85
Guidelines of care for vitiligo. American Academy of Dermatology. J Am Acad Dermatol (1996) 0.85
Dermal-epidermal deposition of complement components and properdin in systemic lupus erythematosus. Br J Dermatol (1975) 0.85
Leukocyte function in granuloma annulare. Br J Dermatol (1979) 0.85
Guidelines of care for cutaneous adverse drug reactions. American Academy of Dermatology. J Am Acad Dermatol (1996) 0.82
The particulate (speckled-like thread) nuclear staining pattern: species and cellular distribution of Ro/SSA antigen. J Clin Lab Immunol (1987) 0.82
Immunopathology of cicatricial pemphigoid: studies of complement deposition. J Invest Dermatol (1977) 0.82
The complement system in bullous pemphigoid. IV. Chemotactic activity in blister fluid. Clin Immunol Immunopathol (1976) 0.82
Guidelines of care for androgenetic alopecia. American Academy of Dermatology. J Am Acad Dermatol (1996) 0.82
Focal dermal hypoplasia in a father and daughter. J Am Acad Dermatol (1981) 0.82
Neonatal pemphigus foliaceus. Arch Dermatol (1995) 0.82
Scleroderma-like changes in chronic graft vs host disease. Arch Dermatol (1977) 0.82
Immunofluorescent studies of dermatomyositis. Dermatologica (1972) 0.82
Pulmonary elastic tissue in generalized elastolysis (cutis laxa) and Marfan's syndrome: a light and electron microscopic study. J Invest Dermatol (1975) 0.82
Neonatal lupus erythematosus. A report of three cases associated with anti-Ro/SSA antibodies. Arch Dermatol (1985) 0.81